The global demand for Head Lice Infestation Treatment Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Head lice are small insects that feed on the blood of the human scalp. They are a common problem and highly contagious. They can also be hard to get rid of. The eggs are known as nits. It spread from person to person by head-to-head contact through direct contact with the hair of an infested person. Head lice infestation is known to cause itching. It is primarily treated with over-the-counter and prescription medications, including Permethrin, Ivermectin, Spinosad, Malathion, and Pyrethrin. These medications work by killing lice and laid eggs.
Market Dynamics
Head lice infestation is a common health problem with a significant burden. The disease is widespread around the world but is more common in school-age children worldwide. Head lice infestation is highest in children aged 6-11 with around 20% and lowest in children aged 13-15 with approximately 5.3%. Head lice infestation is known to cause higher among a population with low socio-economic and poor hygiene conditions. The factors like long-haired pupils, frequency of bathing and washing hair, sharing combs, beds, towels, hair color, parents' literacy, hair thickness, and quantity of dandruff play a significant role in increasing the incidence rate. Growing awareness among parents about treatment, promotions efforts in health and medical education, and availability of over-the-counter medications are fuelling the market growth. However, substantial reliance on home remedies and ayurveda medicine for treating head lice is hampering market growth to some extent.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of head lice infestation treatment. The growth and trends of head lice infestation treatment industry provide a holistic approach to this study.
Market Segmentation
This section of the head lice infestation treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product Type
- OTC Medication (Permethrin, Pyrethrin, Other)
- Prescription Medication (Ivermectin, Spinosad, Malathion, Other)
By Distribution Channel
- Hospitals and Clinics
- Retail Pharmacies
- Other Distribution Channels
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Head Lice Infestation Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Head Lice Infestation Treatment Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the head lice infestation treatment market include Bayer, Alliance Pharmaceuticals Ltd., Omega Pharma, Arbor Pharmaceuticals Inc., Prestige Consumer Healthcare Inc., GlaxoSmithKline, Merck & Co., Inc., Parapro pharmaceuticals, Fleming Medical Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.